SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001493152-20-016805
Filing Date
2020-08-27
Accepted
2020-08-27 06:15:15
Documents
13
Period of Report
2020-08-27

Document Format Files

Seq Description Document Type Size
1 form6-k.htm 6-K 17626
2 ex99-1.htm EX-99.1 55245
3 ex99-2.htm EX-99.2 450990
4 ex99-1_001.jpg GRAPHIC 4321
5 ex99-2logo_001.jpg GRAPHIC 41953
6 ex99-2img_001.jpg GRAPHIC 26448
7 ex99-2img_002.jpg GRAPHIC 6092
8 ex99-2_004.jpg GRAPHIC 10446
9 ex99-2_005.jpg GRAPHIC 8831
10 ex99-2_006.jpg GRAPHIC 4213
11 ex99-2_007.jpg GRAPHIC 4782
12 ex99-2_008.jpg GRAPHIC 4213
13 ex99-2_009.jpg GRAPHIC 4782
  Complete submission text file 0001493152-20-016805.txt   685849
Mailing Address HEMMELRATHER WEG 201 LEVERKUSEN 2M D-51377
Business Address HEMMELRATHER WEG 201 LEVERKUSEN 2M D-51377 011 49 214 876 00
Biofrontera AG (Filer) CIK: 0001712641 (see all company filings)

IRS No.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38396 | Film No.: 201138963
SIC: 2834 Pharmaceutical Preparations